data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
ADC Therapeutics
(NYSE:ADCT)
$8.51
0.56[7.04%]
At close: Jul 1
$7.89
-0.6200[-7.29%]
After Hours: 9:30AM EDT
Day High/Low7.97 - 8.83
52 Week High/Low5.52 - 32
Open / Close7.97 / 8.54
Float / Outstanding33M / 76.8M
Vol / Avg.334.2K / 253.3K
Mkt Cap653.7M
P/E-
50d Avg. Price8.16
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float33M

ADC Therapeutics (NYSE:ADCT), Quotes and News Summary

ADC Therapeutics (NYSE: ADCT)

Day High/Low7.97 - 8.83
52 Week High/Low5.52 - 32
Open / Close7.97 / 8.54
Float / Outstanding33M / 76.8M
Vol / Avg.334.2K / 253.3K
Mkt Cap653.7M
P/E-
50d Avg. Price8.16
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float33M
Benzinga - 5 days ago
Benzinga - Jun 13, 2022, 2:43PM
Benzinga - May 10, 2022, 8:17AM
Benzinga - May 10, 2022, 7:50AM
Benzinga - May 9, 2022, 11:04AM
Benzinga - May 9, 2022, 7:09AM
Benzinga - May 9, 2022, 7:07AM
Benzinga - Apr 12, 2022, 8:52AM
Benzinga - Apr 4, 2022, 7:16AM
Benzinga - Mar 4, 2022, 11:45AM
Benzinga - Mar 4, 2022, 6:42AM
Benzinga - Mar 3, 2022, 7:15AM
Benzinga - Feb 8, 2022, 7:27AM
Benzinga - Feb 1, 2022, 9:40AM
Benzinga - Jan 18, 2022, 7:05AM
Benzinga - Jan 18, 2022, 5:06AM
load more
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS-0.700-0.360 0.3400
REV28.940M46.498M17.558M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

ADC Therapeutics Questions & Answers

Q
How do I buy ADC Therapeutics (ADCT) stock?
A

You can purchase shares of ADC Therapeutics (NYSE: ADCT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are ADC Therapeutics's (ADCT) competitors?
A

There are no as such competitors for ADC Therapeutics.

Q
What is the target price for ADC Therapeutics (ADCT) stock?
A

The latest price target for ADC Therapeutics (NYSE: ADCT) was reported by Morgan Stanley on Tuesday, May 10, 2022. The analyst firm set a price target for 17.00 expecting ADCT to rise to within 12 months (a possible 99.76% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for ADC Therapeutics (ADCT)?
A

The stock price for ADC Therapeutics (NYSE: ADCT) is $8.51 last updated July 1, 2022, 7:59 PM UTC.

Q
Does ADC Therapeutics (ADCT) pay a dividend?
A

There are no upcoming dividends for ADC Therapeutics.

Q
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
A

ADC Therapeutics’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is ADC Therapeutics (ADCT) going to split?
A

There is no upcoming split for ADC Therapeutics.

Q
What sector and industry does ADC Therapeutics (ADCT) operate in?
A

ADC Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NYSE.